GSEA results showed that high expression of PKD1 was enriched in apoptosis, and low expression of PKD1 was enriched in B cell receptor signaling pathway, endometrial cancer, mTOR signaling pathway, and VEGF signaling pathway (Supplementary Figure 2). This evidence concerns the gene PKD1 and endometrial cancer.